Advertisement
Journal Home
Search for

Volume 149, Issue 1, Pages 72-76 (July 2006)


View previous. 37 of 64 View next.

Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis

Francois Dubos, MD, Florence Moulin, MD, Vincent Gajdos, MD, Nathalie De Suremain, MD, Sandra Biscardi, MD, Pierre Lebon, MD, Josette Raymond, MD, PhD, Gerard Breart, MD, Dominique Gendrel, MD, Martin Chalumeau, MD, PhDCorresponding Author Informationemail address

Received 6 July 2005; received in revised form 26 January 2006; accepted 21 February 2006.

Objective

To identify the biologic tests that best distinguish between bacterial and aseptic meningitis in an emergency department (ED).

Study design

All children hospitalized for bacterial meningitis between 1995 and 2004 or for aseptic meningitis between 2000 and 2004 were included in a retrospective cohort study. Predictive values of blood (C-reactive protein, procalcitonin [PCT], white blood cell [WBC] count, neutrophil count) and cerebrospinal fluid (CSF) findings (protein, glucose, WBC count, neutrophil count) available in the ED were determined. Tests with the best predictive value were identified by using univariate and multivariate analyses and ROC curves comparison.

Results

Among the 167 patients included, 21 had bacterial meningitis. The CSF gram-stain and bacterial antigen test had 86% and 60% sensitivity rates, respectively. PCT (≥0.5 ng/mL) and CSF protein (≥0.5 g/L) were the best biologic tests, with 89% and 86% sensitivity rates, 89% and 78% specificity rates, adjusted odds ratios of 108 (95% CI, 15-772) and 34 (95% CI, 5-217), and areas under the ROC curves of 0.95 and 0.93, respectively.

Conclusion

PCT and CSF protein had the best predictive value to distinguish between bacterial and aseptic meningitis in children.

Clinical Epidemiology Unit, Department of Pediatrics, Department of Emergency Medicine, Department of Virology, Department of Bacteriology, Saint-Vincent-de-Paul Hospital, AP–HP, Paris Descartes University, and INSERM U149, Paris, France.

Corresponding Author InformationReprint requests: Dr Martin Chalumeau, Clinical Epidemiology Unit, Department of Pediatrics, Saint-Vincent-de-Paul Hospital, 82, avenue Denfert Rochereau, 75014 Paris, France.

 Supported by the DRC (CRC 03154) and the URC–Cochin, AP-HP, the Fonds d’Etudes et de Recherche du Corps Médical des Hôpitaux de Paris and the Fondation Bayer Santé.

PII: S0022-3476(06)00130-2

doi:10.1016/j.jpeds.2006.02.034


View previous. 37 of 64 View next.

Advertisement